Prevalence of Anti-poliovirus Type 1, 2 and 3 Antibodies in Unvaccinated Italian Travelers

Journal of Travel Medicine

Volumn 11, Issue 1, 2004, Pages 34-36

  Signorini, Liana ^a   Barbi, Maria ^b   Matteelli, Alberto ^a   Binda, Sandro ^b   Didò, Patrizia ^b   Caroppo, Simona ^b   Primache, Valeria ^b   Pisani, Salvatore ^c   Messino, Crescenzo ^d   Brunelli, Maria ^e   Costa, Paolo ^f   Ronca, Enrico ^g   Fausti, Caterina ^a   Castelli, Francesco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c ASL della Provincia di Varese   (Italy)

^d ASL Salò   (Italy)

^e ASL Brescia   (Italy)

^f ASL Provincia di Mantova   (Italy)

^g ASL Cremona   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; POLIOMYELITIS VACCINE; POLIOMYELITIS VIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; ANIMAL CELL; ANTIBODY TITER; ARTICLE; FEMALE; FOOD INTAKE; HUMAN; IMMUNITY; ITALY; MALE; MICROTITER PLATE ASSAY; NONHUMAN; NORMAL HUMAN; POLIOMYELITIS; POLIOMYELITIS VACCINATION; POLIOMYELITIS VIRUS; SEA FOOD; SEROPREVALENCE; TRAVEL; VACCINATION; VEGETABLE; VERO CELL;

EID: 10744226797     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2004.13651     Document Type: Article

References (15)

1. Hull HF. The future of polio eradication. Lancet Infect Dis 2001; 1:299-303.
2. World Health Organization. International travel and health. Vaccine preventable diseases. Poliomyelitis. http://www.who.int/ith/chapter06_07.html (accessed 12 September 2003).
3. Anonymous. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000; 49(RR-5):122.
4. Chen RT, Hausinger S, Dajani AS, et al. Seroprevalence of antibodies against poliovirus in inner-city preschool children. Implications for vaccination policies in the United States. JAMA 1996; 275:1639-1645.
5. Castelli F, Carosi G, Tebaldi A, et al. Age-specific anti-hepatitis A virus seroepidemiology in Italian travelers: indications for anti-hepatitis A vaccination. J Travel Med 1996; 3:214-218.
6. World Health Organization. Guidelines for WHO/EPI collaborative studies on poliomyelitis. Standard procedure for determining immunity to poliovirus using the microneutralization test. WHO/EPI/GEN/93.9. Geneva: World Health Organization, 1993.
7. Anonymous. Certification of poliomyelitis eradication - the Americas, 1994. MMWR 1994; 43:720-722.
8. Anonymous. Certification of poliomyelitis eradication-Western Pacific Region, October 2000. MMWR 2001; 50:1-3.
9. World Health Organization. Mediacentre. Europe on track to be certified polio free on 21 June 2002. www.who.int/multimedia/polio2002 (accessed 12 September 2003).
10. Kubli D, Steffen R, Schar M. Importation of poliomyelitis to industrialized nations between 1975 and 1984: evaluation and conclusions for vaccination recommendations. BMJ 1987; 295:169-171.
11. Schrope M. Plans to eradicate polio hit by virus outbreak in Bulgaria. Nature 2001; 411:405.
12. Dietrich S, Claus H, Schreier E. Immunity status against poliomyelitis in Germany: determination of cut-off values in international units. BMC Infect Dis 2002; 2:2-5.
13. Mastroeni I, Patti AM, Fabrizi A, et al. Immunity status against poliomyelitis in persons 13-14 years old living in Rome. Vaccine 1997; 15:747-750.
14. Stark K, Schonfeld C, Barg J, et al. Seroprevalence and determinants of diphtheria, tetanus and poliomyelitis antibodies among adults in Berlin, Germany. Vaccine 1999; 17:844-850.
15. Altmann D, Brewer D, Rasch C. Vaccination status and illnesses in foreign travelers. Gesundheitswesen 1999; 61(suppl):S106-S109.